Aditxt, Inc.
Market Cap
$3.98K
P/E Ratio
—
EPS
$-6637.20
Dividend Yield
0.00%
52-Week Range
$1.40 — $11679.68
Volume
204.99K
Avg Volume
213.61K
Beta
1.17
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
0.82
P/B (TTM)
-0.01
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-5.51%
ROA (TTM)
-3.58%
ROIC
—
Gross Margin
-34.14%
Operating Margin
-3457.05%
Net Margin
—
Debt/Equity
-0.71
Current Ratio
0.02
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-5589.68%
EPS Growth (5Y)
-3353.77%
Sales Growth (3Y)
+2.26%
Sales Growth (5Y)
+1.36%
EPS Est (This Year)
$-105688900.00
EPS Est (Next Year)
$-107485600.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$3.72
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
21.52K
Float
21.52K
Free Float %
100.00%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2020-06-30
Employees
26
CEO
Amro A. Albanna
Index Membership
—
Website
https://www.aditxt.com
Aditxt, Inc. (ADTX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $3.98K, ADTX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ADTX against other stocks using dozens of fundamental and technical filters.
No, Aditxt, Inc. (ADTX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Aditxt, Inc. (ADTX) has a market capitalization of $3,980, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.